Failure of few cells may cause diabetes: study

Image
Press Trust of India London
Last Updated : Jul 25 2016 | 5:42 PM IST
Diabetes may result from the failure of a privileged few cells, rather than the behaviour of all cells, researchers say, a finding that may pave the way for therapies for the disease.
Researchers used optogenetic and photopharmacological targeting to precisely map the role of the cells required for the secretion of insulin.
The significant role of beta cell 'hubs' in the pancreas has been demonstrated for the first time, suggesting that diabetes may due to the failure of a privileged few cells, rather than the behaviour of all cells, they said.
Researchers believe that the findings could pave the way for therapies that target the 'hubs'.
"It has long been suspected that 'not all cells are equal' when it comes to insulin secretion," said David Hodson, from University of Birmingham in the UK.
"These findings provide a revised blueprint for how our pancreatic islets function, whereby these hubs dictate the behaviour of other cells in response to glucose," said Hodson.
Type 2 diabetes occurs when the pancreas fails to produce enough insulin to function properly, meaning that glucose stays in the blood rather than being converted into energy.
Beta cells make up around 65-80 per cent of the cells in the islets of the pancreas.
Their primary function is to store and release insulin and, when functioning correctly, can respond quickly to fluctuations in blood glucose concentrations by secreting some of their stored insulin, researchers said.
The findings show that just 1-10 per cent of beta cells control islet responses to glucose, they said.
"These specialised beta cells appear to serve as pacemakers for insulin secretion. We found that when their activity was silenced, islets were no longer able to properly respond to glucose," said Hodson.
"This study is interesting as it suggests that failure of a handful of cells may lead to diabetes," said Guy Rutter from Imperial College London in the UK.
The findings were published in the journal Cell Metabolism.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 25 2016 | 5:42 PM IST

Next Story